Monsanto v. Durnell · ¶54

The Riegel Court concluded that FDA’s premarket approval of devices imposed “‘requirements’ under” the Act’s preemption clause, id., at 322, and therefore that FDA’s premarket approval of a medical device preempted state-law claims premised on additional or contrary safety requirements. Id., at 323–325.

slip opinion
Source edition
Passage preview. Read in context for the complete text, notes and references.